The partnership with Fluence expands Tryp's ability to conduct comprehensive clinical trials and leverage invaluable experience and insight from the leader in psychedelic therapy training

San Diego, California--(Newsfile Corp. - May 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp") a pharmaceutical company focused on...